Total Funding
30
51
Total FundingSeries B raised
Growth Score
-2 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
91228
SaNOtize is a biotech company using a platform technology for topical to treat upper respiratory and dermal infections.
- Chris Miller: Co-Founder & CSO
- Gilly Regev: Co-Founder, Chief Strategy and Innovation Officer, DirectorPast Role: SaNOtize, Co-Founder & CEO
About the Company
SaNOtize is a biotech company using a platform technology for topical to treat upper respiratory and dermal infections. The company develops a Nitric Oxide Releasing Solution platform technology to treat and prevent microbial infections, including drug resistant microbes. Its target indications include treatment for strep throat, athlete's
foot, infected wounds, diabetic foot ulcers, sinusitis, cold and flu, and others.
SaNOtize was founded in 2017 by Gilly Regev and Chris Miller and it is headquartered in Vancouver, British Columbia.
